Compounds > beta-lactams
Page last updated: 2024-09-04

beta-lactams and eravacycline

beta-lactams has been researched along with eravacycline in 6 studies

Compound Research Comparison

Studies
(beta-lactams)		Trials
(beta-lactams)		Recent Studies (post-2010)
(beta-lactams)		Studies
(eravacycline)		Trials
(eravacycline)		Recent Studies (post-2010) (eravacycline)
7,5791793,39595393

Protein Interaction Comparison

ProteinTaxonomybeta-lactams (IC50)eravacycline (IC50)
30S ribosomal protein S6Escherichia coli K-120.62
30S ribosomal protein S7Escherichia coli K-120.62
50S ribosomal protein L15Escherichia coli K-120.62
50S ribosomal protein L10Escherichia coli K-120.62
50S ribosomal protein L11Escherichia coli K-120.62
50S ribosomal protein L7/L12Escherichia coli K-120.62
50S ribosomal protein L19Escherichia coli K-120.62
50S ribosomal protein L1Escherichia coli K-120.62
50S ribosomal protein L20Escherichia coli K-120.62
50S ribosomal protein L27Escherichia coli K-120.62
50S ribosomal protein L28Escherichia coli K-120.62
50S ribosomal protein L29Escherichia coli K-120.62
50S ribosomal protein L31Escherichia coli K-120.62
50S ribosomal protein L31 type BEscherichia coli K-120.62
50S ribosomal protein L32Escherichia coli K-120.62
50S ribosomal protein L33Escherichia coli K-120.62
50S ribosomal protein L34Escherichia coli K-120.62
50S ribosomal protein L35Escherichia coli K-120.62
50S ribosomal protein L36Escherichia coli K-120.62
30S ribosomal protein S10Escherichia coli K-120.62
30S ribosomal protein S11Escherichia coli K-120.62
30S ribosomal protein S12Escherichia coli K-120.62
30S ribosomal protein S13Escherichia coli K-120.62
30S ribosomal protein S16Escherichia coli K-120.62
30S ribosomal protein S18Escherichia coli K-120.62
30S ribosomal protein S19Escherichia coli K-120.62
30S ribosomal protein S20Escherichia coli K-120.62
30S ribosomal protein S2Escherichia coli K-120.62
30S ribosomal protein S3Escherichia coli K-120.62
30S ribosomal protein S4Escherichia coli K-120.62
30S ribosomal protein S5Escherichia coli K-120.62
30S ribosomal protein S8Escherichia coli K-120.62
30S ribosomal protein S9Escherichia coli K-120.62
50S ribosomal protein L13Escherichia coli K-120.62
50S ribosomal protein L14Escherichia coli K-120.62
50S ribosomal protein L16Escherichia coli K-120.62
50S ribosomal protein L23Escherichia coli K-120.62
30S ribosomal protein S15Escherichia coli K-120.62
50S ribosomal protein L17Escherichia coli K-120.62
50S ribosomal protein L21Escherichia coli K-120.62
50S ribosomal protein L30Escherichia coli K-120.62
50S ribosomal protein L6Escherichia coli K-120.62
30S ribosomal protein S14Escherichia coli K-120.62
30S ribosomal protein S17Escherichia coli K-120.62
30S ribosomal protein S1Escherichia coli K-120.62
50S ribosomal protein L18Escherichia coli K-120.62
50S ribosomal protein L2Escherichia coli K-120.62
50S ribosomal protein L3Escherichia coli K-120.62
50S ribosomal protein L24Escherichia coli K-120.62
50S ribosomal protein L4Escherichia coli K-120.62
50S ribosomal protein L22Escherichia coli K-120.62
50S ribosomal protein L5Escherichia coli K-120.62
30S ribosomal protein S21Escherichia coli K-120.62
50S ribosomal protein L25Escherichia coli K-120.62
50S ribosomal protein L36 2Escherichia coli K-120.62

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Bassetti, M; Righi, E1
Evans, D; Horn, P; Lee, P; Marsh, A; Slepavicius, A; Solomkin, J; Sutcliffe, JA; Tsai, L1
Higgins, PG; Seifert, H; Stefanik, D; Sutcliffe, JA1
Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A1
Abbaszadeh, F; Baradaran, B; Dehghani, L; Hasani, A; Rezaee, MA; Samadi Kafil, H; Vahhabi, A1
Bakathavatchalam, YD; C, GPD; D, TK; Gopikrishnan, M; Manesh, A; Ramireddy, S; Varghese, RP; Veeraraghavan, B; Walia, K1

Reviews

3 review(s) available for beta-lactams and eravacycline

ArticleYear
Eravacycline for the treatment of intra-abdominal infections.
    Expert opinion on investigational drugs, 2014, Volume: 23, Issue:11

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Tetracyclines

2014
The role of new antimicrobials for Gram-negative infections in daily clinical practice.
    Current opinion in infectious diseases, 2020, Volume: 33, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines

2020
A plethora of carbapenem resistance in
    Journal of chemotherapy (Florence, Italy), 2021, Volume: 33, Issue:3

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteriophages; beta-Lactamases; beta-Lactams; Carbapenems; Cefiderocol; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymyxin B; Tetracyclines

2021

Trials

1 trial(s) available for beta-lactams and eravacycline

ArticleYear
Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial: A Randomized Clinical Trial.
    JAMA surgery, 2017, 03-01, Volume: 152, Issue:3

    Topics: Abdominal Abscess; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; beta-Lactams; Double-Blind Method; Ertapenem; Female; Gram-Negative Bacteria; Humans; Intention to Treat Analysis; Male; Middle Aged; Peritonitis; Tetracyclines; Treatment Outcome; Young Adult

2017

Other Studies

2 other study(ies) available for beta-lactams and eravacycline

ArticleYear
In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii.
    International journal of antimicrobial agents, 2018, Volume: 51, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Colistin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Tetracyclines

2018
Determination of potential combination of non-β-lactam, β-lactam, and β-lactamase inhibitors/β-lactam enhancer against class D oxacillinases producing Acinetobacter baumannii: Evidence from in-vitro, molecular docking and dynamics simulation.
    Journal of cellular biochemistry, 2023, Volume: 124, Issue:7

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cefiderocol; Lactams; Molecular Docking Simulation

2023